There is a long-standing idea that insulin resistance and systemic adiposity increase the risk of cardiovascular (CV) events, however a new school of thought is emerging that defines myocardial insulin resistance as a defense against glucotoxicity and oxidative stress [87, 119]. Here, INS is linked to Insulin resistance.